HTG Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-404
Closed -$227K 90
2026
Q1
$227K Hold
404
0.06% 79
2025
Q4
$273K Hold
404
0.08% 63
2025
Q3
$258K Hold
404
0.09% 67
2025
Q2
$217K Buy
+404
New +$193K 0.08% 67
2024
Q4
Sell
-404
Closed -$204K 68
2024
Q3
$204K Buy
+404
New +$196K 0.1% 66
2024
Q2
Sell
-404
Closed -$218K 61
2024
Q1
$218K Hold
404
0.13% 57
2023
Q4
$224K Buy
+404
New +$190K 0.15% 55

Other funds holding IDXX

HTG Investment Advisors's IDXX Position: Q2 2026 in Review

HTG Investment Advisors sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 404 shares — an estimated $227K sold.

HTG Investment Advisors first reported a position in IDXX in Q4 2023 and held it in 7 quarters. The position peaked at $273K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • HTG Investment Advisors reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • HTG Investment Advisors sold 404 Idexx Laboratories shares in Q2 2026, an estimated $227K.
  • HTG Investment Advisors first reported a position in Idexx Laboratories in Q4 2023 and held it in 7 quarters.
  • HTG Investment Advisors's Idexx Laboratories position peaked at $273K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HTG Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.